United Guardian (UG) EBT Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
United Guardian (UG) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.54 Bn | 626.78 Bn | 17.26 Bn | -265.00 |
| 2 | AbbVie | 441.45 Bn | 434.88 Bn | 12.70 Bn | 636.00 |
| 3 | Merck | 364.78 Bn | 357.64 Bn | 12.21 Bn | 3,137.00 |
| 4 | Novartis Ag | 267.01 Bn | 259.32 Bn | 11.24 Bn | 625.00 |
| 5 | Pfizer | 158.95 Bn | 147.25 Bn | 10.94 Bn | -2,179.00 |
| 6 | Sanofi | 52.54 Bn | 45.16 Bn | 10.79 Bn | -977.00 |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | - |
| 8 | Incyte | 25.36 Bn | 20.82 Bn | 1.57 Bn | 1,581.00 |
| 9 | United Therapeutics | 21.31 Bn | 18.65 Bn | 683.80 Mn | -861.00 |
| 10 | United Guardian | 32.95 Mn | 23.36 Mn | 1.55 Mn | 762.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 762.00 |
| Mar 31, 2026 | -107.00 |
| Dec 31, 2025 | -294.00 |
| Sep 30, 2025 | -355.00 |
| Jun 30, 2025 | 583.00 |
| Mar 31, 2025 | -103.00 |
| Dec 31, 2024 | -1,246.00 |
| Sep 30, 2024 | -454.00 |
| Jun 30, 2024 | -1,089.00 |
| Mar 31, 2024 | -766.00 |
| Dec 31, 2023 | 377.00 |
| Sep 30, 2023 | -1,302.00 |
| Jun 30, 2023 | -2,885.00 |
| Mar 31, 2023 | 701.00 |
| Dec 31, 2022 | 4,874.00 |
| Sep 30, 2022 | -2,286.00 |
| Jun 30, 2022 | -1,923.00 |
| Mar 31, 2022 | -1,910.00 |
| Dec 31, 2021 | 1,333.00 |
| Sep 30, 2021 | -946.00 |